<DOC>
	<DOCNO>NCT00658684</DOCNO>
	<brief_summary>To assess long term safety , tolerability efficacy fesoterodine patient OAB .</brief_summary>
	<brief_title>Long Term Study To Evaluate Safety , Tolerability Efficacy Fesoterodine Overactive Bladder .</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Adult OAB patient present OAB symptom , include micturition &gt; = 8 per day urinary urgency episode &gt; =1 per day . Patient known hypersensitivity active substance ( fesoterodine fumarate ) peanut soya excipients . Patient known neurological disease influence bladder function . Patient complication lower urinary tract pathology potentially responsible urgency incontinence , clinically relevant bladder outlet obstruction pelvic organ prolapse .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>